FDA.reportPublic FDA data

atogepant 30 MG Oral Tablet

RxCUI
2571844
RxNorm name
atogepant 30 MG Oral Tablet
Display name
atogepant 30 MG Oral Tablet
Full name
atogepant 30 MG Oral Tablet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:08

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
QuliptaATOGEPANTAbbVie Inc.8c8ab8f4-32bd-497a-befa-70c8a51d8d522025-09-30Warnings, Adverse reactionsExact identifier
rxcui: 2571844

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
8c8ab8f4-32bd-497a-befa-70c8a51d8d52atogepant 30 MG Oral Tablet [PSN] · atogepant 30 MG Oral Tablet [SCD]219These highlights do not include all the information needed to use QULIPTA safely and effectively. See full prescribing information for QULIPTA . QULIPTA ® (atogepant) tablets, for oral use Initial U.S. Approval: 202120250930